IMMULITE 2000 Anti-HBs

FDA Premarket Approval P010052 S014

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

To remove select inspection criteria from the raw materials used to manufacture immulite substrate reagent

DeviceIMMULITE 2000 Anti-HBs
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantSiemens Healthcare Diagnostics Products, LTD
Date Received2020-08-12
Decision Date2020-09-08
PMAP010052
SupplementS014
Product CodeLOM 
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Siemens Healthcare Diagnostics Products, LTD glyn Rhonwy llanberis, Caernarfon LL55

Supplemental Filings

Supplement NumberDateSupplement Type
P010052Original Filing
S016 2022-09-15 30-day Notice
S015
S014 2020-08-12 30-day Notice
S013 2019-11-25 30-day Notice
S012 2014-11-28 135 Review Track For 30-day Notice
S011 2011-12-19 135 Review Track For 30-day Notice
S010 2011-08-16 30-day Notice
S009 2011-08-08 30-day Notice
S008 2011-02-18 Real-time Process
S007 2009-11-02 Normal 180 Day Track No User Fee
S006
S005 2008-11-10 Normal 180 Day Track No User Fee
S004 2008-02-25 Normal 180 Day Track
S003 2005-08-17 Special (immediate Track)
S002
S001 2002-11-20 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00630414982182 P010052 001
00630414970998 P010052 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.